Prevention of phenytoin-induced gingival overgrowth by lovastatin in mice

American Journal of Pathology

Volumn 185, Issue 6, 2015, Pages 1588-1599

  Assaggaf, Mohammad A ^a   Kantarci, Alpdogan ^b   Sume, Siddika S ^a   Trackman, Philip C ^a  

^a BOSTON UNIVERSITY   (United States)

^b FORSYTH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEVINOLIN; MOLECULAR MARKER; PHENYTOIN; CADHERIN; CONNECTIVE TISSUE GROWTH FACTOR; LOXL2 PROTEIN, MOUSE; OXIDOREDUCTASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; EPILEPSY; EPITHELIAL MESENCHYMAL TRANSITION; GINGIVA OVERGROWTH; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE GROWTH; TISSUE SECTION; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DRUG EFFECTS; GINGIVA; GINGIVAL OVERGROWTH; HUMAN; METABOLISM; PATHOLOGY;

AMINO ACID OXIDOREDUCTASES; ANIMALS; CADHERINS; CONNECTIVE TISSUE GROWTH FACTOR; GINGIVA; GINGIVAL OVERGROWTH; HUMANS; LOVASTATIN; MALE; MICE; MICE, INBRED BALB C; PHENYTOIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84929891398     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.02.004     Document Type: Article

References (48)

1. Y. Ramon, S. Behar, Y. Kishon, and I.S. Engelberg Gingival hyperplasia caused by nifedipine-a preliminary report Int J Cardiol 5 1984 195 206
2. E.M. Rateitschak-Pluss, A. Hefti, R. Lortscher, and G. Thiel Initial observation that cyclosporin-A induces gingival enlargement in man J Clin Periodontol 10 1983 237 246
3. S.A. Black Jr., A.H. Palamakumbura, M. Stan, and P.C. Trackman Tissue-specific mechanisms for CCN2/CTGF persistence in fibrotic gingiva: interactions between cAMP and MAPK signaling pathways, and prostaglandin E2-EP3 receptor mediated activation of the c-JUN N-terminal kinase J Biol Chem 282 2007 15416 15429
4. S.A. Black Jr., and P.C. Trackman Transforming growth factor-beta1 (TGFbeta1) stimulates connective tissue growth factor (CCN2/CTGF) expression in human gingival fibroblasts through a RhoA-independent, Rac1/Cdc42-dependent mechanism: statins with forskolin block TGFbeta1-induced CCN2/CTGF expression J Biol Chem 283 2008 10835 10847
5. S.S. Sume, A. Kantarci, A. Lee, H. Hasturk, and P.C. Trackman Epithelial to mesenchymal transition in gingival overgrowth Am J Pathol 177 2010 208 218
6. M.I. Uzel, A. Kantarci, H.H. Hong, C. Uygur, M.C. Sheff, E. Firatli, and P.C. Trackman Connective tissue growth factor in drug-induced gingival overgrowth J Periodontol 72 2001 921 931
7. M. Alegret, and J.S. Silvestre Pleiotropic effects of statins and related pharmacological experimental approaches Methods Find Exp Clin Pharmacol 28 2006 627 656
8. A. Endo The discovery and development of HMG-CoA reductase inhibitors J Lipid Res 33 1992 1569 1582
9. H.H. Hong, M.I. Uzel, C. Duan, M.C. Sheff, and P.C. Trackman Regulation of lysyl oxidase, collagen, and connective tissue growth factor by TGF-beta1 and detection in human gingiva Lab Invest 79 1999 1655 1667
10. N.N. Van Bruaene, L.L. Derycke, C.A.C. Perez-Novo, P.P. Gevaert, G.G. Holtappels, N.N. De Ruyck, C.C. Cuvelier, P.P. Van Cauwenberge, and C.C. Bachert TGF-beta signaling and collagen deposition in chronic rhinosinusitis J Allergy Clin Immunol 124 2009 253 259
11. A. Millanes-Romero, N. Herranz, V. Perrera, A. Iturbide, J. Loubat-Casanovas, J. Gil, T. Jenuwein, A. Garcia de Herreros, and S. Peiro Regulation of heterochromatin transcription by Snail1/LOXL2 during epithelial-to-mesenchymal transition Mol Cell 52 2013 746 757
12. G. Moreno-Bueno, F. Salvador, A. Martín, A. Floristán, E.P. Cuevas, V. Santos, A. Montes, S. Morales, M.A. Castilla, A. Rojo-Sebastián, A. Martínez, D. Hardisson, K. Csiszar, F. Portillo, H. Peinado, J. Palacios, and A. Cano Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas EMBO Mol Med 3 2011 528 544
13. T.M. Hassell, and A.F. Hefti Drug-induced gingival overgrowth: old problem, new problem Crit Rev Oral Biol Med 2 1991 103 137
14. P.C. Trackman, and A. Kantarci Connective tissue metabolism and gingival overgrowth Crit Rev Oral Biol Med 15 2004 165 175
15. R.N. Kapur, S. Girgis, T.M. Little, and R.E. Masotti Diphenylhydantoin-induced gingival hyperplasia: its relationship to dose and serum level Dev Med Child Neurol 15 2008 483 487
16. R.A. Seymour, J.S. Ellis, and J.M. Thomason Risk factors for drug-induced gingival overgrowth J Clin Periodontol 27 2000 217 223
17. T. Modéer, G. Dahllöf, and P. Otteskog The effect of the phenytoin metabolite p-HPPH on proliferation of gingival fibroblasts in vitro Acta Odontol Scand 40 1982 353 357
18. T. Salo, K.S. Oikarinen, and A.I. Oikarinen Effect of phenytoin and nifedipine on collagen gene expression in human gingival fibroblasts J Oral Pathol Med 19 1990 404 407
19. A. Kantarci, Z. Nseir, Y.-S. Kim, S.S. Sume, and P.C. Trackman Loss of basement membrane integrity in human gingival overgrowth J Dent Res 90 2011 887 893
20. L. Heijl, and Y. Sundin Nitrendipine-induced gingival overgrowth in dogs J Periodontol 60 1989 104 112
21. W. Seibel, N.A. Yahia, L.B. McCleary, L.J. Lesko, and T.M. Hassell Cyclosporine-induced gingival overgrowth in beagle dogs J Oral Pathol Med 18 1989 240 245
22. C.M. Kanno, J.A. Oliveira, J.F. Garcia, A.L. Castro, and M.M. Crivelini Effects of cyclosporin, phenytoin, and nifedipine on the synthesis and degradation of gingival collagen in tufted capuchin monkeys (Cebus apella): histochemical and MMP-1 and -2 and collagen I gene expression analyses J Periodontol 79 2008 114 122
23. T.M. Hassell, S. Roebuck, R.C. Page, and S.H. Wray Quantitative histopathologic assessment of developing phenytoin-induced gingival overgrowth in the cat J Clin Periodontol 9 1982 365 372
24. E. Fu, S. Nieh, H.L. Chang, and S.L. Wang Dose-dependent gingival overgrowth induced by cyclosporin in rats J Periodontol 66 1995 594 598
25. H. Ishida, T. Kondoh, M. Kataoka, S. Nishikawa, T. Nakagawa, I. Morisaki, J.-I. Kido, T. Oka, and T. Nagata Factors influencing nifedipine-induced gingival overgrowth in rats J Periodontol 66 1995 345 350
26. S. Nieh, E. Fu, H.L. Chang, S.L. Wang, and U.M. Wikesjö Histopathologic alterations of periodontium in cyclosporin-treated rats. Is the periodontium a target tissue for the drug? J Clin Periodontol 23 1996 730 736
27. S. Nishikawa, T. Nagata, I. Morisaki, T. Oka, and H. Ishida Pathogenesis of drug-induced gingival overgrowth: a review of studies in the rat model J Periodontol 67 1996 463 471
28. Y. Asahara, F. Nishimura, H. Yamada, K. Naruishi, M. Kataoka, J-i Kido, T. Nagata, and Y. Murayama Mast cells are not involved in the development of cyclosporin A-induced gingival hyperplasia: a study with mast cell-deficient mice J Periodontol 71 2000 1117 1120
29. S.H. Ashrafi, B. Atassi, R. Erickson, and T. Sabet Migration of epithelium during phenytoin-dependent gingival overgrowth in mice Scanning Microsc 7 1993 1247 1253
30. A.T. Meller, V.M. Rumjanek, C. Sansone, and S. Allodi Oral mucosa alterations induced by cyclosporin in mice: morphological features J Periodontal Res 37 2002 412 415
31. W.W. Hallmon, and J.A. Rossmann The role of drugs in the pathogenesis of gingival overgrowth: a collective review of current concepts Periodontol 2000 21 1999 176 196
32. R.I. Marshall, and P.M. Bartold A clinical review of drug-induced gingival overgrowths Aust Dent J 44 1999 219 232
33. N.A. Bhowmick, R. Zent, M. Ghiassi, M. McDonnell, and H.L. Moses Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity J Biol Chem 276 2001 46707 46713
34. M. Zeisberg, J.-I. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, and R. Kalluri BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury Nat Med 9 2003 964 968
35. C. Liu, Z. Wu, and H.-C. Sun The effect of simvastatin on mRNA expression of transforming growth factor-beta1, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket Int J Oral Sci 1 2009 90 98
36. C.Y. Song, B.C. Kim, and H.S. Lee Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-β1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells Transl Res 151 2008 27 35
37. M. He, H. Kubo, K. Ishizawa, A.E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya The role of the receptor for advanced glycation end-products in lung fibrosis Am J Physiol Lung Cell Mol Physiol 293 2007 L1427 L1436
38. R. Moll, M. Mitze, U.H. Frixen, and W. Birchmeier Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas Am J Pathol 143 1993 1731 1742
39. J.-S. Nam, Y. Ino, M. Sakamoto, and S. Hirohashi Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis Jpn J Cancer Res 93 2002 1020 1028
40. E. Lozano, M. Betson, and V.M.M. Braga Tumor progression: small GTPases and loss of cell-cell adhesion Bioessays 25 2003 452 463
41. T.A. Golper, D.R. Illingworth, C.D. Morris, and W.M. Bennett Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria Am J Kidney Dis 13 1989 312 320
42. A. Igarashi, K. Nashiro, K. Kikuchi, S. Sato, H. Ihn, M. Fujimoto, G.R. Grotendorst, and K. Takehara Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders J Invest Dermatol 106 1996 729 733
43. Y. Ito, J. Aten, R.J. Bende, B.S. Oemar, T.J. Rabelink, J.J. Weening, and R. Goldschmeding Expression of connective tissue growth factor in human renal fibrosis Kidney Int 53 1998 853 861
44. S. Sonnylal, X. Shi-Wen, P. Leoni, K. Naff, C.S. Van Pelt, H. Nakamura, A. Leask, D. Abraham, G. Bou-Gharios, and B. de Crombrugghe Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis Arthritis Rheum 62 2010 1523 1532
45. G. Akiri, E. Sabo, H. Dafni, Z. Vadasz, Y. Kartvelishvily, N. Gan, O. Kessler, T. Cohen, M. Resnick, M. Neeman, and G. Neufeld Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo Cancer Res 63 2003 1657 1666
46. V. Barry-Hamilton, R. Spangler, D. Marshall, S. McCauley, H.M. Rodriguez, M. Oyasu, A. Mikels, M. Vaysberg, H. Ghermazien, C. Wai, C.A. Garcia, A.C. Velayo, B. Jorgensen, D. Biermann, D. Tsai, J. Green, S. Zaffryar-Eilot, A. Holzer, S. Ogg, D. Thai, G. Neufeld, P. Van Vlasselaer, and V. Smith Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment Nat Med 16 2010 1009 1017
47. H. Peinado, M. del Carmen Iglesias-de la Cruz, D. Olmeda, K. Csiszar, K.S.K. Fong, S. Vega, M.A. Nieto, A. Cano, and F. Portillo A molecular role for lysyl oxidase-like 2 enzyme in Snail regulation and tumor progression EMBO J 24 2005 3446 3458
48. M. Iftikhar, P. Hurtado, M.V. Bais, N. Wigner, D.N. Stephens, L.C. Gerstenfeld, and P.C. Trackman Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation J Biol Chem 286 2011 909 918